Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD

In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking?

Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 69
• Can Topiramate Replace FDA-Approved Medications for Alcohol Use Disorder?